Today’s AI Top Pick: BKV
7/30/2026 · Highly Shorted Oversold screen · a free sample of K3vl4r’s AI-curated picks.
AI-ranked from a screened shortlist, with entry strategy, targets, and risks.
View the live BKV price forecast →
BKV is the cleanest 'screen-plus-confirmation' setup in the pool. It's the only name that combines a genuinely strong fundamental profile (fundamental_score 8, PE 7.06, PEG 0.69, ROE 15.9, profit margin 27.91%, sales YoY +52.41%, analyst recom 1.23, target upside +44.8%) with a fully bullish multi-timeframe forecast: 1h +23.0/+17.2/+22.8%, 4h +17.6/+28.2/+23.0%, 1d +9.1/+14.5/+11.1% — every single horizon points up with no negative outlier, kronos bullish_prob 1.0 and near_term_bullish 0.8. Unlike most of the pool, these are not moonshot forecasts on a busted micro-cap; they are moderate, credible numbers on a $2.55B profitable energy name. Entry timing is favorable: BKV sits at 23.31 with pos_in_21bar_range_pct = 0 on the daily and 1.9 on the 4h, drawdown -14.77% from the 21-bar high, and RSI 30.94 — textbook oversold on the very screen this pool is built around, without the vertical bounce that usually kills reward/risk. Recent news is supportive rather than dangerous: Simply Wall St. flagging 28% undervaluation, Susquehanna maintaining positive stance (even if PT trimmed to $35), and Q2 earnings on deck as a near-term catalyst. Why BKV over the higher-forecast names: ARRY, CRML, ASPI, INV, and RDW all show 60-130% mid/long forecasts, but every one of them has either deep unprofitability (ROE -22 to -139, negative margins) or weekly forecasts that reverse sharply lower (ARRY 1wk long +107 but ASPI 1wk -38, INV wildly volatile). ADTN has the second-best fundamentals but is fighting two fresh PT cuts (B. Riley to $21, Needham to $14) and shows a 1wk short forecast of -8.4%. MNRO has full TF alignment but PE 65.98 and profit margin 0.59% make it a value trap. REPL just crashed on FDA staff concerns — an automatic avoid. TOYO's fundamentals rival BKV's but the daily forecast is only +1.2% short-term and its expected_return_pct is actually negative (-6.2%). BKV is the trade where the screen thesis (oversold, high short interest) is backed by a real business with growing earnings, a supportive analyst chorus, and forecasts that align across every visible timeframe. Waiting invites the short-covering squeeze into Q2 earnings; the entry today is at range-low with defined risk.
- Short float 20.18% cuts both ways — a soft Q2 print (earnings on deck per 7/16 release) could accelerate the drawdown before the squeeze catalyst arrives
- Natural gas / power price sensitivity: energy sector beta means a macro risk-off can override the oversold setup regardless of company fundamentals
- Debt/equity 0.57 is manageable but not fortress; any credit-market wobble hits levered E&P names first
- 1d forecast short-term is only +9.1% — this is a base-hit setup, not a 50%+ ripper like ARRY/CRML; sizing must reflect the more modest expected move
- Weekly timeframe data not provided — cannot confirm longer-term trend is intact, so this is a 2–6 week trade, not a multi-quarter hold without further review
| # | Symbol | Verdict | Score | Read |
|---|---|---|---|---|
| 1 | BKV | BUY NOW | 8.4 | Only name pairing fund_score 8 with all-timeframes-positive forecast at range-low; RSI 30.94, dd -14.77%, supportive analyst news. |
| 2 | MNRO | BUY NOW | 7.8 | Perfect multi-TF alignment, near_term 1.0, all timeframes at pos_in_range 0 — best pure tape setup even if PE 65.98 is rich. |
| 3 | ADTN | BUY PULLBACK | 7.3 | Strong fundamentals (PEG 0.17, target +123%) and monster 1h forecast +94.7%, but two fresh analyst PT cuts and 1wk short forecast -8.4% argue for patience. |
| 4 | ARRY | BUY NOW | 7.1 | Full TF alignment, near_term 1.0, 1wk long +107.3%, dd -32.5%; Q2 preview weak but forecast tape overrides. |
| 5 | BTDR | BUY NOW | 6.8 | 43.35% short float + all-TF positive forecasts (1h +47%, 4h +33%, 1d +17-53%) = highest squeeze potential in pool. |
| 6 | CRML | BUY NOW | 6.7 | 1h/4h/1d forecasts +78-123%, near_term 1.0, target upside +265% — no fundamentals to lean on but rare-earth narrative + CEO defense on 7/28. |
| 7 | TOYO | BUY PULLBACK | 6.5 | Fund_score 8, PEG 0.02, ROE 46.52%, but 1d forecast only +1.2% short-term and expected_return_pct actually negative (-6.2%) — wait for tape to confirm. |
| 8 | RDW | BUY NOW | 6.3 | 1h fc +98/+104/+93%, near_term 1.0, dd -33.75% on 1d; weekly long fc -16.4% is the caution flag. |
| 9 | TSSI | BUY PULLBACK | 6.2 | Fund_score 3.25, 1d fc mid +77.6%, positive AI-narrative headlines, but 1wk forecast collapses to -52% long-term. |
| 10 | CRMD | BUY PULLBACK | 6.1 | PE 3.42, ROE 65.6%, profit margin 45.25% — cheap and profitable, but near_term_bullish only 0.2 and RBC just trimmed PT to $13. |
| 11 | MP | BUY PULLBACK | 6.0 | 1h/4h forecasts +55-70%, near_term 0.8, but 1wk fc turns -25.6% long — rare-earth story intact, timing questionable. |
| 12 | ASPI | BUY PULLBACK | 5.9 | 1d fc +104% mid, near_term 1.0, dd -42% on 1d, but 1wk -39% long and salesYoY +511% masks -644% profit margin. |
| 13 | ENPH | BUY PULLBACK | 5.8 | Profitable (operMargin 25.63%, ROE 13%) but recom 2.66 (only Hold) and multiple analysts cutting PTs on 7/29 into Q2 print. |
| 14 | RUN | BUY PULLBACK | 5.7 | PE 4.43 and profit margin 17.94% look attractive but debtEq 4.45 is dangerous; near_term 0.6, 1d short fc -0.6%. |
| 15 | LAC | BUY PULLBACK | 5.5 | 1h/4h forecasts +67-86%, near_term 0.6, but 1wk short fc -12.9% and no revenue yet — pure spec. |
| 16 | HIVE | BUY PULLBACK | 5.4 | Chardan initiated Buy $7.50 PT, but 4h forecasts flat +1-9% and $130M note issuance is dilutive overhang. |
| 17 | INV | BUY PULLBACK | 5.3 | 1wk long fc +241% is eye-popping but PS 72.48 and profit margin -5226% make this pure lottery ticket. |
| 18 | KULR | WAIT | 5.2 | Selling bitcoin holdings for $21.5M suggests cash need; near_term 0.4, 1h long fc only +5.5%. |
| 19 | ABAT | BUY PULLBACK | 5.1 | Restored $57M DOE grant is a real catalyst but operMargin -390% and near_term 0.2 kill immediate entry. |
| 20 | FIP | WAIT | 5.0 | debtEq 3.96 is dangerous, 1wk fc mixed, but near_term 0.6 and multiple analyst covers offer floor. |
| 21 | UAMY | WAIT | 4.9 | 1h fc +99/+128/+150% but 1wk fc -13/-26/-44% — the setup is decaying, not building. |
| 22 | WW | WAIT | 4.7 | Only 1d timeframe available, PE 0.12 is a distress signal not a bargain, debtEq 1.76. |
| 23 | UUUU | WAIT | 4.5 | White Mesa expansion is a positive but 1wk fc -37% short/mid/long and PS 31.63 stretched. |
| 24 | LUNR | WAIT | 4.4 | 1h fc +207% but appears on Zacks 'Strong Sell' list 7/28 and Q2 print pending — incoherent signals. |
| 25 | PLUG | WAIT | 4.2 | ROE -128.9%, profit margin -227%, fund_score 0; no TF data to confirm — pure hope trade. |
| 26 | PSIX | WAIT | 4.0 | Fund_score 7.5 (ROE 75.67%, PE 5.74) is compelling but no multi-TF data provided AND new CEO effective 8/17 injects uncertainty. |
| 27 | AMR | AVOID | 3.3 | Cut FY26 met coal guidance from 14.54-15.4M to 13.2-14.0M tons on 7/27 — screen setup broken by fresh guidance cut. |
| 28 | CRWV | AVOID | 3.0 | CEO sold $25M of stock while sweetening $2.6B loan terms amid debt concerns and 52-week low — do not catch. |
| 29 | REPL | AVOID | 2.0 | FDA staff raised doubts on RP1 melanoma drug 7/28; stock crashed 32% — thesis destroyed pre-AdCom. |
| 30 | QCLS | AVOID | 1.2 | 1d/1wk forecasts -96% to -100%, terminated license agreement with Lightsolver — screen match is a mirage. |
Get AI top picks & forecasts on any stock
K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord